Ligand-controlled divergent enantioselective hydroarylation of cyclobutenes.

Renming Pan, Jie Zhu, Xinjie Zhou, Minyan Wang, Ping Lu

Abstract read

In one paragraph

Article in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Renming PanResearch Center for Molecular Recognition and Synthesis, Department of Chemistry, Fudan University 220 Handan Lu Shanghai 200433 P. R. China plu@fudan.edu.cn.

Jie ZhuState Key Laboratory of Coordination Chemistry, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Chemistry and Chemical Engineering, Nanjing University Nanjing 210093 P. R. China wangmy@nju.edu.cn.

Xinjie ZhouResearch Center for Molecular Recognition and Synthesis, Department of Chemistry, Fudan University 220 Handan Lu Shanghai 200433 P. R. China plu@fudan.edu.cn.

Minyan WangState Key Laboratory of Coordination Chemistry, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Chemistry and Chemical Engineering, Nanjing University Nanjing 210093 P. R. China wangmy@nju.edu.cn.

Ping LuResearch Center for Molecular Recognition and Synthesis, Department of Chemistry, Fudan University 220 Handan Lu Shanghai 200433 P. R. China plu@fudan.edu.cn.ORCID https://orcid.org/0000-0002-2259-2700

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The palladium-catalyzed enantioselective redox-neutral coupling of alkenes with organoboronic reagents remains an unfulfilled challenge. Herein, we report a divergent palladium-catalyzed enantioselective hydroarylation of cyclobutenes with arylboronic acids, affording both 1,2- and 1,3-hydroarylation products. The regioselectivity was tuned by judicious choice of chiral ligands. The palladium-hydride species was generated from a palladium catalyst and arylboronic acid or

Identifiers

PMID41104162

DOI10.1039/d5sc05740j

PMCPMC12523589

What Socratic holds

Textmetadata

LicenceCC BY-NC

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.